These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 23042218)
21. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
22. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art. Fariello RG Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984 [No Abstract] [Full Text] [Related]
23. Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders. Männisto PT; Venäläinen J; Jalkanen A; García-Horsman JA Drug News Perspect; 2007 Jun; 20(5):293-305. PubMed ID: 17878957 [TBL] [Abstract][Full Text] [Related]
24. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review]. Strnad J; Bahro M Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539 [No Abstract] [Full Text] [Related]
25. Pharmacologic approaches to cognitive deficits in Alzheimer's disease. Peskind ER J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483 [TBL] [Abstract][Full Text] [Related]
26. Cognition enhancers between treating and doping the mind. Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672 [TBL] [Abstract][Full Text] [Related]
27. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Bäckman L; Jones S; Berger AK; Laukka EJ; Small BJ Neuropsychology; 2005 Jul; 19(4):520-31. PubMed ID: 16060827 [TBL] [Abstract][Full Text] [Related]
28. Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target. Barak S; Weiner I Pharmacol Biochem Behav; 2011 Aug; 99(2):164-89. PubMed ID: 21420999 [TBL] [Abstract][Full Text] [Related]
29. Cognitive enhancers for the treatment of neuropsychiatric disorders: clinical and preclinical investigations. Kantak KM; Hofmann SG Pharmacol Biochem Behav; 2011 Aug; 99(2):113-5. PubMed ID: 21316387 [No Abstract] [Full Text] [Related]
30. Measuring cognitive change in Alzheimer's disease clinical drug trials. Harrison JE J Nutr Health Aging; 2007; 11(4):327-9. PubMed ID: 17653492 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature. Conant R; Schauss AG Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642 [TBL] [Abstract][Full Text] [Related]